CDER Deputy Galson Will Run Drug Center For At Least Six Months
This article was originally published in The Tan Sheet
Executive Summary
Center for Drug Evaluation & Research Deputy Director Steve Galson, MD, will be acting center director during the period when FDA is expected to announce a decision on forced Rx-to-OTC switches